Some new oxime ethers of types 7 and 8, in which the methyleneaminoxy group, CN−O, of oxiconazole 6 is in an inverted atomic sequence, were synthesized and tested for their antifungal activities. Among them, the type 7 compounds, such as the N-ethoxy-morpholino-substituted derivatives 7l−o (Table 1), showed good antifungal properties against the Candida strains tested, with minimum inhibitory concentration (MIC) values similar to those of the reference drug 6. A remarkable result was obtained with these types of azoles, which had shown a cidal character against Candida albicans, while the reference drug oxiconazole was only fungistatic in the same tests. This fact may be seen from a comparison of the MIC values with those of the minimum fungicidal concentration (MFC) values for most of the type 7 compounds assayed that have shown differences between the MIC and the MFC, which are lower than three double diluitions. A simple molecular modeling of the P450 14-α-sterol demethylase from C. albicans (Candida P450DM) was built in order to understand how the structural differences between type 7 compounds and oxiconazole 6 can induce different antifungal profiles. The results of this work seem to confirm that it is possible to reverse the atomic sequence of the methyleneaminoxy group, CN−O, of 6, obtaining new imidazoles possessing good antifungal properties.
|Autori interni:||ROSSELLO, ARMANDO|
|Autori:||ROSSELLO A; S. BERTINI; A. LAPUCCI; M. MACCHIA; A. MARTINELLI; S. RAPPOSELLI; E. HERREROS; B. MACCHIA|
|Titolo:||Synthesis, Antifungal Activity, and Molecular Modeling Studies of New Inverted Oxime Ethers of Oxiconazole|
|Anno del prodotto:||2002|
|Digital Object Identifier (DOI):||10.1021/jm020980t|
|Appare nelle tipologie:||1.1 Articolo in rivista|